Order Article Reprints

Claesen K, Sim Y, Bracke A, De bruyn M, De Hert E, Vliegen G, Hotterbeekx A, Vujkovic A, van Petersen L, De Winter FHR, et al. Activation of the Carboxypeptidase U (CPU, TAFIa, CPB2) System in Patients with SARS-CoV-2 Infection Could Contribute to COVID-19 Hypofibrinolytic State and Disease Severity Prognosis. Journal of Clinical Medicine. 2022; 11(6):1494. https://doi.org/10.3390/jcm11061494

Claesen, Karen, Yani Sim, An Bracke, Michelle De bruyn, Emilie De Hert, Gwendolyn Vliegen, An Hotterbeekx, Alexandra Vujkovic, Lida van Petersen, Fien H. R. De Winter, and et al. 2022. "Activation of the Carboxypeptidase U (CPU, TAFIa, CPB2) System in Patients with SARS-CoV-2 Infection Could Contribute to COVID-19 Hypofibrinolytic State and Disease Severity Prognosis" Journal of Clinical Medicine 11, no. 6: 1494. https://doi.org/10.3390/jcm11061494

Claesen, K., Sim, Y., Bracke, A., De bruyn, M., De Hert, E., Vliegen, G., Hotterbeekx, A., Vujkovic, A., van Petersen, L., De Winter, F. H. R., Brosius, I., Theunissen, C., van Ierssel, S., van Frankenhuijsen, M., Vlieghe, E., Vercauteren, K., Kumar-Singh, S., De Meester, I., & Hendriks, D. (2022). Activation of the Carboxypeptidase U (CPU, TAFIa, CPB2) System in Patients with SARS-CoV-2 Infection Could Contribute to COVID-19 Hypofibrinolytic State and Disease Severity Prognosis. Journal of Clinical Medicine, 11(6), 1494. https://doi.org/10.3390/jcm11061494